Results 9,721-9,740 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Is there a panel for counsel as well?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Are they procured in the same way?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: There is a panel in place.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I do not enjoy asking this question but I must ask it from a governance perspective. The counsel acting in that case are Eoin McCullough SC, John Healy SC and Seamus Breen BL. Is that correct?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Were they all on the panel?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Is Seamus Breen a relative?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: He was on the panel and selected by-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Mr. Breen stood aside in his selection.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Mr. Breen stood aside and Seamus Breen did not make the panel and is no longer on the panel. Is that the position?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I have no doubt that he is eminently qualified. It came up in research and I had to ask this question from a governance perspective. As I said, I do not particularly enjoy asking the question. I may return to the thalidomide issue in the afternoon. How am fixed for time?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Does the Chair want to cut me short?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I want to make sure Deputy Murphy has enough time also.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I do not want to eat into anybody's time.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I want to touch on a few points on the CervicalCheck issue, if I may, and address other issues in the afternoon. I do not want to take too much time from Deputy Murphy. Are many random audits carried out on cervical smear results that were found to be normal in the period from 2015 to 2018?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Were they included for that period from 2015 to 2018?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Mr. McCallion said earlier that the audit is about to recommence.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Will slides from that period be looked at?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: The whole governance area was raised as a problem. Has all of that been dealt with now? Does everybody know who is responsible for what?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Have timelines been set?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: The Scally report refers to a compelling requirement on clinicians to disclose. Was the issue of reprisal against clinicians whether from the HSE, hospital management, the Minister or the Department, part of the issue with disclosure and, if so, how is it planned to address that?